BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26935255)

  • 1. Connexin32‑mediated antitumor effects of suicide gene therapy against hepatocellular carcinoma: In vitro and in vivo anticancer activity.
    Wu L; Zhou WB; Shen F; Liu W; Wu HW; Zhou SJ; Li SW
    Mol Med Rep; 2016 Apr; 13(4):3213-9. PubMed ID: 26935255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSVtk/GCV system on hepatoma carcinoma cells: Construction of the plasmid pcDNA3.1‑pAFP-TK and targeted killing effect.
    Li YF; Yuan YY; Zhang YM; Zhao N; Zhang Q; Meng FX; Gao RP; Yu BF; Zhang YH; Guo R; Wang HL; Xie J; Xu J; Qin Q; Dong XS
    Mol Med Rep; 2017 Jul; 16(1):764-772. PubMed ID: 28560395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and αVβ3 Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells.
    Li J; Zhou P; Li L; Zhang Y; Shao Y; Tang L; Tian S
    PLoS One; 2016; 11(7):e0158592. PubMed ID: 27391603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma.
    Yu BF; Wu J; Zhang Y; Sung HW; Xie J; Li RK
    Cancer Gene Ther; 2013 May; 20(5):290-7. PubMed ID: 23598435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of plasmid vector pAFP-HSVtk-IRES2-EGFP and its effect on the cytotoxicity of ganciclovir to hepatocellular carcinoma.
    Lai Z; Qin Q; Yu B; Xie J; Gao R; Zhang T; Li C; Niu K; Xu J
    Chin Med J (Engl); 2014; 127(12):2337-41. PubMed ID: 24931253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer.
    Chen W; Yan C; Hou J; Pu J; Ouyang J; Wen D
    Urol Oncol; 2008; 26(4):397-405. PubMed ID: 18367126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma.
    Liu C; Wen C; Wang X; Wei Y; Xu C; Mu X; Zhang L; Wang X; Tian J; Ma P; Meng F; Zhang Q; Zhao N; Yu B; Gong T; Guo R; Wang H; Xie J; Sun G; Li G; Zhang H; Qin Q; Xu J; Dong X; Wang L
    Exp Cell Res; 2019 Oct; 383(1):111496. PubMed ID: 31306654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-trans retinoic acid enhances bystander effect of suicide-gene therapy against medulloblastomas.
    Li S; Gao Y; Pu K; Ma L; Song X; Liu Y
    Neurosci Lett; 2011 Oct; 503(2):115-9. PubMed ID: 21872643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [All-trans retinoic acid augments the bystander effect of herpes simplex virus thymidine kinase/ganciclovir system in the treatment of tongue carcinoma cell line].
    Wang AX; Huang HZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):24-6. PubMed ID: 12760771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery.
    Tanaka M; Fraizer GC; De La Cerda J; Cristiano RJ; Liebert M; Grossman HB
    Gene Ther; 2001 Jan; 8(2):139-48. PubMed ID: 11313783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [All-trans retinoic acid enhances bystander effect of suicide-gene therapy against androgen-unresponsive prostate cancer].
    Chen WG; Yan CY; Hou JQ; Wen DG; Pu JX; Wang HB
    Zhonghua Nan Ke Xue; 2008 Feb; 14(2):122-5. PubMed ID: 18390175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation.
    Shibata MA; Morimoto J; Otsuki Y
    Cancer Gene Ther; 2002 Jan; 9(1):16-27. PubMed ID: 11916241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene.
    Qu L; Wang Y; Gong L; Zhu J; Gong R; Si J
    Oncol Rep; 2013 Apr; 29(4):1435-40. PubMed ID: 23354806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
    Gao Ding Cheng ; An W; Dai J
    Cell Res; 1999 Sep; 9(3):225-35. PubMed ID: 10520605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways.
    Zhao B; Zhao W; Wang Y; Xu Y; Xu J; Tang K; Zhang S; Yin Z; Wu Q; Wang X
    Oncotarget; 2015 Apr; 6(12):10116-33. PubMed ID: 25426556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes.
    Tanaka T; Yamasaki H; Mesnil M
    Mol Carcinog; 2001 Mar; 30(3):176-80. PubMed ID: 11301478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions.
    Vrionis FD; Wu JK; Qi P; Waltzman M; Cherington V; Spray DC
    Gene Ther; 1997 Jun; 4(6):577-85. PubMed ID: 9231074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
    Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids.
    Finocchiaro LM; Bumaschny VF; Karara AL; Fiszman GL; Casais CC; Glikin GC
    Cancer Gene Ther; 2004 May; 11(5):333-45. PubMed ID: 15107812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.